he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源地址
- 2022-05-02遗传病是什么病 身体有这4个问题易患遗传病
- 2022-04-28卒中后癫痫选用用药有哪些?解答卒中后癫痫的4大问题
- 2022-04-262013年国际抗癫痫联合会抗癫痫药性使用指南
- 2022-03-31十个女人,八个贫血,五种常见的便宜货,让你充满气血
- 2022-02-21基本的癫痫病病因有哪些
- 2022-02-07就其的癫痫病病因有哪些
- 癫痫猝死:凶手是谁?
- 2013国际抗癫痫联合会抗癫痫药用指南
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- 凌腾医学宣布,卡妥索双抗对介苗治疗失败的非肌层浸润性膀胱癌的第一次临床试验已经完成
- 受精卵在同一个房间后几天植入 植入有什么感觉?
- 预测癫痫患者再入院风险
- 为什么光疗能有效治疗白癜风?
- 你在中国当医生的五少痛点?
- 十个女人,八个贫血,五种常见的便宜货,让你充满气血
- 癫痫定位新方法:无框架立体定向脑电图技术
- 羊角病能生孩子吗?
- 2015第31届国际癫痫大会(IEC)
- 癫痫的治疗方法 中医拔罐治疗癫痫的小方法(2)
- 如何治疗女性癫痫?
- 癫痫治疗 中医治疗癫痫不用担心
- 妇科解剖记忆公式有点长,非常详细!
- 肩带向下滑动,胸罩向上移动,这四个信号表明女性应该换胸罩。!
- 抗癫痫药物预防新发癫痫:任重而道远
- 三种治疗花斑癣的偏方
- 延迟性癫痫患者中风预后较差
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- 泰国试管婴儿/什么情况下冷胚移植更好?!
- 新版医保药品2800种 逢进必谈有哪些药?我们来看看!
- 治疗脑炎后遗症的方法有哪些?
- 2015 神经系统疾病诊疗进展
- Medpage Today:不同类型的抗癫痫药物更有利
- 三庚酸酯可治疗1型转运体缺陷综合征
- 小孩儿癫痫病好不好清领呢
- 治疗癫痫病的最佳作法如何能治好
- 女性癫痫病怎么治疗才能有效性
- 长期酗酒 需提醒 Marchiafa-Bignami 病
- 去肇庆儿童医院|小儿癫痫的病因有哪些?
- 头皮脑电图或机制磁共振成像对局灶性癫痫有定位作用
- 癫痫病的早患者是什么样的
- 治疗癫痫病方法哪种最必需
- 癫痫病反复发烧都有哪些病因
- 【用药问答】癫痫大发作和局限性发作的众所周知治疗为?
- 癫痫病发病根本是怎么回事
- 治癫痫支出要多少
- 治好癫痫病同样的方法是什么